GlassScriptPhysician profile
Maurice M Solis
NPI 1215976105
$1,504.61
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $33.14 · 2021: $824 · 2023: $174 · 2024: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $744.43 | 2021 | |
| W. L. Gore & Associates, INC. | $245.16 | 2020-2024 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic Vascular, INC. | $158.85 | 2019 | |
| Penumbra, INC. | $116.20 | 2024 | Indigo System |
| Endologix LLC | $72.86 | 2023 | Alto Abdominal Stent Graft System |
| Angiodynamics, INC. | $61.24 | 2024 | Alphavac |
| Lemaitre Vascular, INC. | $35.98 | 2023 | Restoreflow, Artegraft Vascular Graft |
| Atricure, INC. | $29.52 | 2019 | |
| Abbott Laboratories | $16.38 | 2024 | Allure Quadra |
| Janssen Pharmaceuticals, INC | $13.29 | 2019 | |
| Cardiovascular Systems INC. | $10.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maurice Solis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.